Potentiation by ammonia of the metabolic effects of pent-4-enoate in isolated rat hepatocytes.

PubWeight™: 0.75‹?›

🔗 View Article (PMC 1144422)

Published in Biochem J on November 15, 1984

Authors

F X Coudé, G Grimber, P Parvy, D Rabier, J Bardet

Articles cited by this

High-yield preparation of isolated rat liver parenchymal cells: a biochemical and fine structural study. J Cell Biol (1969) 20.26

Regulation of hepatic fatty acid oxidation and ketone body production. Annu Rev Biochem (1980) 7.03

The effect of lysine on gluconeogenesis from lactate in rat hepatocytes. Biochem J (1974) 2.19

Control mechanisms of gluconeogenesis and ketogenesis. I. Effects of oleate on gluconeogenesis in perfused rat liver. J Biol Chem (1969) 1.70

Pyridine nucleotide distributions and enzyme mass action ratios in hepatocytes from fed and starved rats. Arch Biochem Biophys (1977) 1.67

Role of anion translocation across the mitochondrial membrane in the regulation of urea synthesis from ammonia by isolated rat hepatocytes. J Biol Chem (1975) 1.52

Hypoglycin and hypoglycin-like compounds. Pharmacol Rev (1969) 1.41

Studies of the mechanism of the hypoglycemic action of 4-pentenoic acid. Proc Natl Acad Sci U S A (1967) 1.40

Hypoglycin and related hypoglycaemic compounds. Br Med Bull (1969) 1.36

Control factors affecting gluconeogenesis in perfused rat liver. Effects of 4-pentenoic acid. J Biol Chem (1970) 1.35

Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Effects of the free acids and their carnitine esters on coenzyme A-dependent oxidations in rat liver mitochondria. Biochem J (1973) 1.30

Degradation of unsaturated fatty acids. Identification of intermediates in the degradation of cis-4-decenoly-CoA by extracts of beef-liver mitochondria. Eur J Biochem (1978) 1.30

Mitochondrial and cytosolic NADPH systems and isocitrate dehydrogenase indicator metabolites during ureogensis from ammonia in isolated rat hepatocytes. Eur J Biochem (1977) 1.24

Biochemical effects of the hypoglycaemic compound pent-4-enoic acid and related non-hypoglycaemic fatty acids. Oxidative phosphorylation and mitochondrial oxidation of pyruvate, 3-hydroxybutyrate and tricarboxylic acid-cycle intermediates. Biochem J (1968) 1.23

Action of the oral hypoglycemic agent 2-tetradecylglycidic acid on hepatic fatty acid oxidation and gluconeogenesis. J Biol Chem (1979) 1.19

Rate-limiting steps of gluconeogenesis in liver cells as determined with the aid of fluoro-dicarboxylic acids. Eur J Biochem (1972) 1.15

The regulation of gluconeogenesis. The effect of pent-4-enoic acid on gluconeogenesis and on the gluconeogenic metabolite concentrations of isolated perfused rat liver. J Biol Chem (1970) 1.06

In vivo induction of 4-enoyl-CoA reductase by clofibrate in liver mitochondria and its effect on pent-4-enoate metabolism. Biochem Biophys Res Commun (1980) 0.99

Metabolism of 4-pentenoic acid and inhibition of thiolase by metabolites of 4-pentenoic acid. Biochemistry (1983) 0.93

Protection of rats against hypoglycin and pent-4-enoate toxicity by pretreatment with clofibrate [proceedings]. Biochem Soc Trans (1979) 0.92

Evidence for a modified pathway of linoleate degradation. Metabolism of 2,4-decadienoyl coenzyme A. J Biol Chem (1982) 0.92

A simple radioisotopic assay of acetylcarnitine and acetyl-CoA at picomolar levels. Anal Biochem (1981) 0.85

Inhibition of urea synthesis by pent-4-enoate associated with decrease in N-acetyl-L-glutamate concentration in isolated rat hepatocytes. Biochim Biophys Acta (1979) 0.83

Articles by these authors

A beta-galactosidase hybrid protein targeted to nuclei as a marker for developmental studies. Proc Natl Acad Sci U S A (1987) 3.23

The clinical phenotype of succinic semialdehyde dehydrogenase deficiency (4-hydroxybutyric aciduria): case reports of 23 new patients. Pediatrics (1997) 1.86

Differential effects of inactivated Axin1 and activated beta-catenin mutations in human hepatocellular carcinomas. Oncogene (2006) 1.84

Targeted expression of a dominant-negative EGF-R in the kidney reduces tubulo-interstitial lesions after renal injury. J Clin Invest (2000) 1.68

Spi-1/PU.1 transgenic mice develop multistep erythroleukemias. Mol Cell Biol (1996) 1.63

Recognition and management of fatty acid oxidation defects: a series of 107 patients. J Inherit Metab Dis (1999) 1.63

Arrhythmias and conduction defects as presenting symptoms of fatty acid oxidation disorders in children. Circulation (1999) 1.57

Clinical approach to inherited peroxisomal disorders: a series of 27 patients. Ann Neurol (1998) 1.49

Hyperammonemia with reduced ornithine, citrulline, arginine and proline: a new inborn error caused by a mutation in the gene encoding delta(1)-pyrroline-5-carboxylate synthase. Hum Mol Genet (2000) 1.47

Mutation of the fumarase gene in two siblings with progressive encephalopathy and fumarase deficiency. J Clin Invest (1994) 1.45

Facial anomalies in D-2-hydroxyglutaric aciduria. Am J Med Genet (1999) 1.42

Human trifunctional protein deficiency: a new disorder of mitochondrial fatty acid beta-oxidation. Biochem Biophys Res Commun (1992) 1.42

Clinical outcome of long-term management of patients with vitamin B12-unresponsive methylmalonic acidemia. J Pediatr (1994) 1.39

[A new cause of increased troponin levels: junctional tachycardia]. Arch Mal Coeur Vaiss (2003) 1.38

Hair and skin disorders as signs of mitochondrial disease. Pediatrics (1999) 1.38

Liver transplantation in urea cycle disorders. Eur J Pediatr (1999) 1.35

[Amino acids and trisomy 21]. Ann Genet (1992) 1.34

Methylmalonic and propionic acidaemias: management and outcome. J Inherit Metab Dis (2005) 1.27

Overexpression of regenerating islet-derived 1 alpha and 3 alpha genes in human primary liver tumors with beta-catenin mutations. Oncogene (2006) 1.24

Transgenic mice for MTCP1 develop T-cell prolymphocytic leukemia. Blood (1998) 1.18

Clinical outcome and long-term management of 17 patients with propionic acidaemia. Eur J Pediatr (1996) 1.17

Neutrophil-derived long-lived oxidants in cystic fibrosis sputum. Am J Respir Crit Care Med (1995) 1.17

Methylmalonic and propionic acidurias: management without or with a few supplements of specific amino acid mixture. J Inherit Metab Dis (2006) 1.17

Recurrent episodes of bizarre behavior in a boy with ornithine transcarbamylase deficiency: diagnostic failure of protein loading and allopurinol challenge tests. J Pediatr (1994) 1.16

[Dressler's syndrome: constrictive pericarditis following myocardial infarction operated on with success]. Arch Mal Coeur Vaiss (1975) 1.16

Hyperinsulinism and hyperammonemia syndrome: report of twelve unrelated patients. Pediatr Res (2001) 1.15

Alpha-ketoglutarate dehydrogenase deficiency presenting as congenital lactic acidosis. J Pediatr (1992) 1.13

Oxidation of fatty acids in cultured fibroblasts: a model system for the detection and study of defects in oxidation. Pediatr Res (1982) 1.12

Clinical aspects of mitochondrial disorders. J Inherit Metab Dis (1992) 1.09

Urea cycle defects: management and outcome. J Inherit Metab Dis (2005) 1.08

Cholestasis is a marker for hepatocellular carcinomas displaying beta-catenin mutations. J Pathol (2007) 1.07

A new neonatal case of N-acetylglutamate synthase deficiency treated by carbamylglutamate. J Inherit Metab Dis (1995) 1.05

Ornithine transcarbamylase deficiencies in human males. Kinetic and immunochemical classification. Biochim Biophys Acta (1982) 1.05

Hepatitis B virus X gene product acts as a transactivator in vivo. J Hepatol (1994) 1.03

Induction of urea cycle enzymes by glucagon and dexamethasone in monolayer cultures of adult rat hepatocytes. J Biol Chem (1982) 1.02

[Inventory of different intracellular peptidase activities in Streptococcus thermophilus. Purification and properties of a dipeptide hydrolase and an aminopeptidase]. Biochimie (1973) 1.01

Patterns of expression of position-dependent integrated transgenes in mouse embryo. Proc Natl Acad Sci U S A (1990) 1.01

Inhibition of ureagenesis by valproate in rat hepatocytes. Role of N-acetylglutamate and acetyl-CoA. Biochem J (1983) 0.99

Time-course development of differentiated hepatocarcinoma and lung metastasis in transgenic mice. J Hepatol (1991) 0.99

Long-term outcome in methylmalonic aciduria: a series of 30 French patients. Mol Genet Metab (2009) 0.97

5-Oxoprolinuria: a cause of neonatal metabolic acidosis. Acta Paediatr (2001) 0.97

In vivo activity of the hepatitis B virus core promoter: tissue specificity and temporal regulation. J Virol (1995) 0.97

Correlation between blood ammonia concentration and organic acid accumulation in isovaleric and propionic acidemia. Pediatrics (1982) 0.94

Partial duplication [dup. TCAC (178)] and novel point mutations (T125M, G188R, A209V, and H302L) of the ornithine transcarbamylase gene in congenital hyperammonemia. Hum Mutat (1996) 0.93

Definitive cure of hyperammonemia by liver transplantation in urea cycle defects: report of three cases. Transplant Proc (1994) 0.92

Acute effects of glucagon on citrulline biosynthesis. Biochem J (1982) 0.92

Action of the antiepileptic drug, valproic acid, on fatty acid oxidation in isolated rat hepatocytes. Biochem Biophys Res Commun (1983) 0.91

Diet-dependent carcinogenesis of pancreatic islets and liver in transgenic mice expressing oncogenes under the control of the L-type pyruvate kinase gene promoter. Oncogene (1992) 0.91

Early alterations of plasma free amino acids in chronic renal failure. Clin Chim Acta (1990) 0.90

Renal synthesis of arginine in chronic renal failure: in vivo and in vitro studies in rats with 5/6 nephrectomy. Kidney Int (1993) 0.90

Fatal hyperammonemia resulting from a C-to-T mutation at a MspI site of the ornithine transcarbamylase gene. Hum Genet (1991) 0.89

The neurogenic weakness, ataxia and retinitis pigmentosa (NARP) syndrome mtDNA mutation (T8993G) triggers muscle ATPase deficiency and hypocitrullinaemia. Eur J Pediatr (1999) 0.89

Therapeutic use of carbamylglutamate in the case of carbamoyl-phosphate synthetase deficiency. J Inherit Metab Dis (1996) 0.89

[Hemodynamic effects at rest and exertion of a new partial beta-agonist (cicloprolol) in moderated cardiac failure]. Arch Mal Coeur Vaiss (1988) 0.89

[Hyperglycinuria induced by n-dipropylacetate. Possible model of propionic acidemia]. Nouv Presse Med (1977) 0.89

Serum citrulline and rejection in small bowel transplantation: a preliminary report. Transplantation (2001) 0.88

Persistent hypocitrullinaemia as a marker for mtDNA NARP T 8993 G mutation? J Inherit Metab Dis (1998) 0.88

Clinical assessment of infarct size by serial determinations of serum creatine phosphokinase activity. Eur J Cardiol (1979) 0.88

Carrier detection in a partially dominant X-linked disease: ornithine transcarbamylase deficiency. Hum Genet (1990) 0.88

A 3-base pair in-frame deletion in exon 8 (delGlu272/273) of the ornithine transcarbamylase gene in late-onset hyperammonemic coma. Hum Mutat (1996) 0.88

Posterior rupture of the interventricular septum after acute myocardial infarction: successful early surgical repair. Ann Thorac Surg (1977) 0.88

[Role of acetylglutamate in the stimulation of citrullinogenesis by glucagon]. C R Seances Acad Sci D (1980) 0.87

[Aortic insufficiency in Takayasu's disease. Apropos of 3 surgically treated cases and review of the literature]. Arch Mal Coeur Vaiss (1984) 0.87

Reversibility of alcoholic cardiomyopathy with abstention from alcohol. Cardiology (1979) 0.87

Comparison of a new method for the direct and simultaneous assessment of LDL- and HDL-cholesterol with ultracentrifugation and established methods. Clin Chem (2000) 0.87

Serum citrulline as a marker of acute cellular rejection for intestinal transplantation. Transplant Proc (2002) 0.87

Comparative effects of enoximone and nitroglycerin on left ventricular performance and regional wall motion in ischaemic cardiomyopathy. Br J Clin Pract Suppl (1988) 0.87

Defects in activation and transport of fatty acids. J Inherit Metab Dis (1999) 0.87

Arginine remains an essential amino acid after liver transplantation in urea cycle enzyme deficiencies. J Inherit Metab Dis (1991) 0.87

Plasma lysine concentration and availability of 2-ketoglutarate in liver mitochondria. J Inherit Metab Dis (2002) 0.87

[Symptomatic left ventricular dysfunction and Behçet disease. Report of 2 cases]. Arch Mal Coeur Vaiss (2003) 0.87

A mechanism for valproate-induced hyperammonemia. Adv Exp Med Biol (1982) 0.87

Regional left ventricular function assessed by contrast angiography in acute myocardial infarction. Circulation (1979) 0.86

Retrograde catheterization of left ventricle through mechanical aortic prostheses. Eur Heart J (1987) 0.86

Most cases of medium-chain acyl-CoA dehydrogenase deficiency escape detection in France. Hum Genet (1996) 0.86

Left ventricular compliance in acute myocardial infarction in man. Cardiovasc Res (1977) 0.86

Protective effects of SR 57746A in central and peripheral models of neurodegenerative disorders in rodents and primates. Neuroscience (1993) 0.86

Approach to the patient with a fatty acid oxidation disorder. Prog Clin Biol Res (1992) 0.86

Transcriptional selectivity in early mouse embryos: a qualitative study. Nucleic Acids Res (1991) 0.85

Renal transplantation in 4 patients with methylmalonic aciduria: a cell therapy for metabolic disease. Mol Genet Metab (2013) 0.85

[Effect of n-dipropyl-acetate on the elimination of urinary amino acids]. Helv Paediatr Acta (1978) 0.85